Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB11990InvestigationalSmall molecule
MK0812 has been used in trials studying the treatment of Relapsing-Remitting Multiple Sclerosis.
- Mechanism
- Curator reviewed
Pharmacologically active on C-C chemokine receptor type 2
- Formula / weight
- C24H34F3N3O3 · 469.549 g/mol (avg)
- Code names
- MK-0812
Resolves to
Structure
InChIKey
MTMDXAIUENDNDL-RJSMDTJLSA-NSMILESCO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@](C1)(C(C)C)C(=O)N1CCC2=NC=C(C=C2C1)C(F)(F)FTargets
What you can answer from here — as of November 05, 2026
Which drugs share a target with MK-0812, and which of those have an active Phase 3 trial?